Xenetic Biosciences, Inc. (XBIO:NASDAQ) soared at $5.3, representing a gain of 65.1%. On Wed, Jul 28, 2021, XBIO:NASDAQ hit a New 2-Week High of $3.21. The stock appeared on our News Catalysts scanner on Wed, Jul 28, 2021 at 02:24 PM in the 'PRIVATE PLACEMENT' category. From Wed, Jul 14, 2021, the stock recorded 60.00% Up Days and 45.45% Green Days
The stock spiked on Fri, Jul 23, 2021 at $4.75 with a volume of 300M+.
About Xenetic Biosciences, Inc. (XBIO:NASDAQ)
Xenetic Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics.
Top 10 Gainers:
- Xenetic Biosciences, Inc. (XBIO:NASDAQ), 65.11%
- Intec Pharma Ltd. (NTEC:NASDAQ), 48.09%
- LendingClub Corporation (LC:NYSE), 47.82%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- Golden Star Resources Ltd. (GSS:NYSEMKT), 24.76%
- MKTW (MKTW:NASDAQ), 23.13%
- PRFX (PRFX:NASDAQ), 20.14%
- OpGen, Inc. (OPGN:NASDAQ), 19.11%
- BON (BON:NASDAQ), 16.99%
- Iterum Therapeutics plc (ITRM:NASDAQ), 16.79%